↓ Skip to main content

American Association for Cancer Research

Hallmarks of RET and Co-occuring Genomic Alterations in RET-aberrant CancersHallmarks of RET

Overview of attention for article published in Molecular Cancer Therapeutics, September 2021
Altmetric Badge

About this Attention Score

  • In the top 5% of all research outputs scored by Altmetric
  • Among the highest-scoring outputs from this source (#30 of 4,071)
  • High Attention Score compared to outputs of the same age (98th percentile)
  • High Attention Score compared to outputs of the same age and source (99th percentile)

Mentioned by

twitter
262 X users

Citations

dimensions_citation
24 Dimensions

Readers on

mendeley
24 Mendeley
Title
Hallmarks of RET and Co-occuring Genomic Alterations in RET-aberrant CancersHallmarks of RET
Published in
Molecular Cancer Therapeutics, September 2021
DOI 10.1158/1535-7163.mct-21-0329
Pubmed ID
Authors

Jacob J. Adashek, Aakash P. Desai, Alexander Y. Andreev-Drakhlin, Jason Roszik, Gilbert J. Cote, Vivek Subbiah

X Demographics

X Demographics

The data shown below were collected from the profiles of 262 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 24 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 24 100%

Demographic breakdown

Readers by professional status Count As %
Student > Master 3 13%
Other 2 8%
Researcher 2 8%
Student > Bachelor 1 4%
Professor 1 4%
Other 4 17%
Unknown 11 46%
Readers by discipline Count As %
Medicine and Dentistry 7 29%
Biochemistry, Genetics and Molecular Biology 3 13%
Chemistry 1 4%
Unknown 13 54%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 150. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 17 October 2023.
All research outputs
#276,748
of 25,559,053 outputs
Outputs from Molecular Cancer Therapeutics
#30
of 4,071 outputs
Outputs of similar age
#7,237
of 434,204 outputs
Outputs of similar age from Molecular Cancer Therapeutics
#1
of 52 outputs
Altmetric has tracked 25,559,053 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 98th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 4,071 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 8.9. This one has done particularly well, scoring higher than 99% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 434,204 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 98% of its contemporaries.
We're also able to compare this research output to 52 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 99% of its contemporaries.